PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH by A. Sabljic, M. Sedinic, R. Kusec, V. Pejsa, M. Lucijanic

Get full text

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID-19 PATIENTS by M. Lucijanic, I. Jurin, M. Sedinic, E. Soric, A. Sabljic, I. Hadzibegovic, T. Lucijanic, R. Kusec

Get full text

P1040: HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS by M. Lucijanic, I. Krecak, E. Soric, D. Galusic, H. Holik, V. Perisa, M. Moric Peric, I. Zekanovic, R. Kusec

Get full text

P1039: PALPABLE SPLEEN SIZE IS PROGNOSTIC IN PRIMARY BUT NOT SECONDARY MYELOFIBROSIS by M. Lucijanic, I. Krecak, E. Soric, D. Galusic, H. Holik, V. Perisa, M. Moric Peric, I. Zekanovic, R. Kusec

Get full text

P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR H... by D. Galusic, S. Basic - Kinda, A. Pijuk, V. Milunovic, B. Dreta, N. Franjic, B. Coha, J. Sincic – Petricevic, P. Gacina, V. Pejsa, M. Lucijanic, I. Aurer

Get full text

PB2054: HIP AND KNEE OSTEOARTHRITIS IN PHILADELPHIA CHROMOSOME-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS by H. Holik, I. Krečak, I. Samardžić, D. Pilipac, B. Coha, V. Gverić-Krečak, I. Vučinić Ljubičić, M. Lucijanić, I. Rajkovača Latić, L. Vinković, B. Miškić, S. Zupančić Šalek

Get full text

P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY by M. Lucijanic, E. Soric, M. Sedinic, A. Sabljic, S. Tomasinec, A. Pasaric, M. Ivic, T. Vasilj, D. Cicic, Z. Jonjic, M. Pirsic, Z. Mitrovic, Z. Prka, V. Pejsa, R. Kusec, O. Jaksic

Get full text